Risk factor
Very poor trading liquidity
Profitability factor
Good growth
About
MicroBase Technology Corp., founded in 1997 and headquartered in Taoyuan City, Taiwan, specializes in providing critical drug administration solutions to patients and medical professionals throughout Taiwan. A key area of their expertise involves pioneering the development of non-silicon-based Micro-Electro-Mechanical Systems (MEMS) by leveraging LIGA technology. This sophisticated method facilitates the engineering and production of extremely small devices and micron-sized components. Their product offerings include "Pocket Air," an innovative inhalation device designed to assist individuals with respiratory conditions, and "PharMatrix," a line of micro-needle products tailored for convenient at-home application by women.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV